Form 4: Amphastar Pharmaceuticals Executive Yakob Liawatidewi Reports Tax Liability Share Withholding

Yakob Liawatidewi, EVP Corp Admin Center at Amphastar Pharmaceuticals, reports the withholding of 1,221 shares to cover tax liabilities related to vesting restricted stock units.

Summary

• On March 6, 2024, Yakob Liawatidewi, EVP Corp Admin Center at Amphastar Pharmaceuticals, had 1,221 shares of common stock withheld to cover tax liabilities.
• This was related to the vesting of restricted stock units (RSUs).
• The price per share for the transaction was $46.31.
• Following the transaction, Liawatidewi directly owns 79,202 shares of common stock.
• Liawatidewi also indirectly owns 2,459 shares through the Yakob and Sunmoon Trust dated July 25, 2013, where she serves as a trustee.

Sentiment

Score: 5

Explanation: This is a neutral report on a routine transaction related to executive compensation and tax obligations.

Industry Context

This filing is a routine disclosure related to executive compensation and tax obligations, common in the pharmaceutical industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, such as Amphastar Pharmaceuticals, and are comparable to similar filings made by executives at companies like Teva Pharmaceutical Industries or Mylan (now Viatris).
• The withholding of shares for tax liabilities is a common method of handling RSU vesting, aligning with practices seen across the pharmaceutical sector.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it relates to an individual executive's tax obligations.

Key Dates